Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized <sup>3</sup>He Magnetic Resonance Imaging in Patients With Lung Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 41802548.
- Also identified by DOI 10.1016/j.ijrobp.2026.02.243.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Computed tomography ventilation imaging (CTVI) has great potential for clinical translation and has been validated in numerous studies. However, previous studies focused on image comparisons, and little is known about the dosimetric implications of "good" or "poor" image correlations or agreements in radiation therapy (RT). This study assessed the agreement of dose-function metrics between CTVI and hyperpolarized <sup>3</sup>He magnetic resonance imaging (MRI) as a reference. This study included 27 patients with non-small cell lung cancer who were randomized in a phase 2 trial examining <sup>3</sup>He MRI-guided functional avoidance RT. All patients underwent 4-dimensional computed tomography and <sup>3</sup>He MRI. CTVI was retrospectively created. Pearson correlation and Bland-Altman analyses were performed to assess the agreements between <sup>3</sup>He MRI- and CTVI-based well-ventilated lung dose-function metrics, including functional V<sub>20Gy</sub> (fV<sub>20Gy</sub>) and functional mean lung dose, of RT plans. To assess the associations between dose-function metrics and clinical outcomes, we dichotomized patients by a clinically meaningful decline in Functional Assessment of Cancer Therapy-Lung: Lung Cancer Subscale (≥3-point) and the occurrence of grade ≥2 radiation pneumonitis and compared the dose-function metrics between the 2 groups. Correlation coefficients of dose-function metrics were 0.80 to 0.82 for both fV<sub>20Gy</sub> and functional mean lung dose. Bland-Altman analyses showed a mean difference < 1% for fV<sub>20Gy</sub>, with 95% limits of agreement of 8% to 10%, indicating that agreements varied among patients. Among Lung Cancer Subscale-evaluable patients (n = 20), those with a ≥3-point decline (n = 8) had higher fV<sub>20Gy</sub> than those without (CTVI: 28.2% vs 21.9%, P = .05; <sup>3</sup>He MRI: 26.2% vs 22.3%, P = 0.24). Patients with grade ≥2 radiation pneumonitis (n = 4) also showed higher values than those without (CTVI: 28.2% vs 24.2%, P = .34; <sup>3</sup>He MRI: 27.0% vs 23.5%, P = .25). CTVI demonstrated strong correlations and small bias in dose-function metrics with <sup>3</sup>He MRI, including fV<sub>20Gy</sub> and functional mean lung dose. These findings support CTVI as a ventilation surrogate for functional avoidance RT.